Omalizumab Effect on Eosinophilic Otitis Media and Sinusitis: A Case Report
-
- Oshima Hidetoshi
- Tohoku University School of Medicine
-
- Kawase Tetsuaki
- Tohoku University School of Medicine Tohoku University Graduate School of Biomedical Engineering
-
- Kobayashi Toshimitsu
- Tohoku University School of Medicine
Bibliographic Information
- Other Title
-
- 抗ＩｇＥモノクローナル抗体（オマリズマブ）が奏功した好酸球性中耳炎・副鼻腔炎例
- 臨床 抗IgEモノクローナル抗体(オマリズマブ)が奏功した好酸球性中耳炎・副鼻腔炎例
- リンショウ コウIgE モノクローナル コウタイ オマリズマブ ガ ソウコウ シタ コウサンキュウセイ チュウジエン フクビクウエンレイ
Search this article
Abstract
Omalizumab, a monoclonal antibody to human IgE, is used to treat severe asthma and is reportedly effective in other allergic diseases. We report a case of eosinophilic otitis media and sinusitis improved by omalizumab treatment. A 66-year-old woman with severe asthma, eosinophilic otitis media, and sinusitis had omalizumab started to treat asthma. Besides rapidly improving asthma symptoms, it ameliorated eosinophilic otitis media and sinusitis, confirming its hoped for effectiveness.<br>
Journal
-
- Practica Oto-Rhino-Laryngologica
-
Practica Oto-Rhino-Laryngologica 104 (5), 319-323, 2011
The Society of Practical Otolaryngology
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204264146944
-
- NII Article ID
- 10027972553
-
- NII Book ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL BIB ID
- 11102602
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed